arrow_back Back to App

Down Syndrome Research Support: New Programs and Improved Care.

This act establishes a new research, training, and investigation program related to Down syndrome, known as the INCLUDE Project. Its goal is to enhance understanding of the condition, develop new therapies, and improve the quality of life for individuals with Down syndrome and their families. This means citizens with Down syndrome can expect better medical care and new treatment options.
Key points
Creation of the INCLUDE Project to coordinate research on Down syndrome, including its impact on development and health.
Increase in the number of clinical trials available for individuals with Down syndrome, including testing new medications and therapies.
Focus on identifying early risk factors and developing personalized treatments for individuals with Down syndrome.
Improving the quality of life for individuals with Down syndrome and their families through better understanding and treatment of co-occurring conditions.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_1838
Sponsor: Sen. Hickenlooper, John W. [D-CO]
Process start date: 2025-05-21
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

DeOndra Dixon INCLUDE Project Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_1838.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-05-21.

What are the main provisions?

Key points include:

  • Creation of the INCLUDE Project to coordinate research on Down syndrome, including its impact on development and health.
  • Increase in the number of clinical trials available for individuals with Down syndrome, including testing new medications and therapies.
  • Focus on identifying early risk factors and developing personalized treatments for individuals with Down syndrome.
  • Improving the quality of life for individuals with Down syndrome and their families through better understanding and treatment of co-occurring conditions.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hickenlooper, John W. [D-CO].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health